NCT06692933View on ClinicalTrials.gov

Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 20, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
Interaction
Interventions
DRUG

Cannabidiol in the form of hemp

Cannabidiol (30 mg) in the form of an orally administered hemp oil softgel

DRUG

Clopidogrel

75 mg oral clopidogrel

Trial Locations (1)

99202

RECRUITING

Washington State University College of Pharmacy and Pharmaceutical Sciences, Spokane

All Listed Sponsors
collaborator

Office of Dietary Supplements (ODS)

NIH

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Washington State University

OTHER